Combined, the findings support a hypothesis that an inducible TGF-β2-TGFβR pathway functions to control the sensitivity of HNSCC cells to TKIs targeting dominant RTK pathways. This evidence concerns the gene TGFB2 and head and neck squamous cell carcinoma.